Spray drying formulation of albendazole microspheres by experimental design. In vitro–in vivo studies

References

• Herrero EP, Valle EMMD, Galán MA. Development of a new technology for the production of microcapsules based in atomization processes. Chem Eng J 2006;117:137–42
   Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Chetoni P, et al. Ophthalmic delivery systems based on drug–polymer–polymer ionic ternary interaction: in vitro and in vivo characterization. Eur J Pharm Biopharm 2006;62:59–69
   PubMed Web of Science ®Google Scholar
• Quinteros DA, Rigo VR, Kairuz AFJ, et al. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 2008;33:72–9
   PubMed Web of Science ®Google Scholar
• Lankalapalli S, Kolapalli RM. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya-chitosan polyelectrolyte complexes. Drug Dev Ind Pharm 2012;38:815–24
   PubMed Web of Science ®Google Scholar
• Wang FQ, Li P, Zhang JP, et al. A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery. Drug Dev Ind Pharm 2010;36:867–77
   PubMed Web of Science ®Google Scholar
• Liu YH, Zhu X, Zhou D, et al. pH-sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system. Drug Dev Ind Pharm 2011;37:868–74
   PubMed Web of Science ®Google Scholar
• Rozenberg BA, Tenne R. Polymer-assisted fabrication of nanoparticles and nanocomposites. Prog Polym Sci 2008;33:40–112
   Web of Science ®Google Scholar
• Dreve S, Kacso I, Popa A, et al. Structural investigation of chitosan-based microspheres with some anti-inflammatory drugs. J Mol Struct 2011;997:78–86
   Web of Science ®Google Scholar
• Lu Z, Chen W, Hamman JH. Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation. Drug Dev Ind Pharm 2010;36:539–46
   PubMed Web of Science ®Google Scholar
• El-Gibaly I, Meki AMA, Abdel-Ghaffar SK. Novel B melatonin-loaded chitosan microcapsules: in vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver. Int J Pharm 2003;260:5–22
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei W, Lv P, et al. Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm 2011;77:11–19
   PubMed Web of Science ®Google Scholar
• Xu Q, Xia Y, Wang C-H, Pack DW. Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy. J Control Release 2012;163:130–5
   PubMed Web of Science ®Google Scholar
• Pillai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: chemistry, solubility and fiber formation. Prog Polym Sci 2009;34:641–78
   Web of Science ®Google Scholar
• Kasaai MR. A review of several reported procedures to determine the degree of N-acetylation for chitin and chitosan using infrared spectroscopy. Carbohyd Polym 2008;71:497–508
   Web of Science ®Google Scholar
• Liu Y, Tang J, Chen X, Xin JH. A templating route to nanoporous chitosan materials. Carbohyd Res 2005;340:2816–20
   PubMed Web of Science ®Google Scholar
• Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 1998;24:979–93
   PubMed Web of Science ®Google Scholar
• Marudova M, Lang S, Brownsey GJ, Ring SG. Pectin-chitosan multilayer formation. Carbohydr Res 2005;340:2144–9
   PubMed Web of Science ®Google Scholar
• Marudova M, MacDougall AJ, Ring SG. Pectin-chitosan interactions and gel formation. Carbohydr Res 2004;339:1933–9
   PubMed Web of Science ®Google Scholar
• Lin Y, Chen Q, Luo H. Preparation and characterization of N-(2-carboxybenzyl)chitosan as a potential pH-sensitive hydrogel for drug delivery. Carbohyd Res 2007;342:87–95
   PubMed Web of Science ®Google Scholar
• Zambito Y, Di Colo G. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J Pharm Pharm Sci 2003;6:274–81
   PubMed Web of Science ®Google Scholar
• Yu CY, Yin BC, Zhang W, et al. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloid Surface B 2009;68:245–9
   PubMed Web of Science ®Google Scholar
• Kas HS. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 1997;14:689–711
   PubMed Web of Science ®Google Scholar
• Itoh K, Hirayama T, Takahashi A, et al. In situ gelling pectin formulations for oral drug delivery at high gastric pH. Int J Pharm 2007;335:90–6
   PubMed Web of Science ®Google Scholar
• Gómez-Burgaz M, García-Ochoa B, Torrado-Santiago S. Chitosan–carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin. Int J Pharm 2008;359:135–43
   PubMed Web of Science ®Google Scholar
• Lü S, Liu M, Ni B. An injectable oxidized carboxymethylcellulose/N-succinyl-chitosan hydrogel system for protein delivery. Chem Eng J 2010;160:779–87
   Web of Science ®Google Scholar
• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011;420:1–10
   PubMed Web of Science ®Google Scholar
• Castillo JA, Palomo-Canales J, Garcia JJ, et al. Preparation and characterization of albendazole beta-cyclodextrin complexes. Drug Dev Ind Pharm 1999;25:1241–8
   PubMed Web of Science ®Google Scholar
• Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 2003;86:141–59
   PubMed Web of Science ®Google Scholar
• Vogt M, Kunath K, Dressman JB. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur J Pharm Biopharm 2008;68:330–7
   PubMed Web of Science ®Google Scholar
• Simi SP, Saraswathi R, Sankar C, et al. Formulation and evaluation of albendazole microcapsules for colon delivery using chitosan. Asian Pac J Trop Med 2010;3:374–8
   Web of Science ®Google Scholar
• Daniel-Mwambete K, Torrado S, Cuesta-Bandera C, et al. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 2004;272:29–36
   PubMed Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004;274:1–33
   PubMed Web of Science ®Google Scholar
• Stulzer HK, Tagliari MP, Parize AL, et al. Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying. Mater Sci Eng B 2009;29:387–92
   Google Scholar
• Lee J-S, Kim JS, Lee HG. γ-Oryzanol-loaded calcium pectinate microparticles reinforced with chitosan: optimization and release characteristics. Colloid Surface B 2009;70:213–17
   PubMed Web of Science ®Google Scholar
• Leonardi D, Lamas MC, Olivieri AC. Multiresponse optimization of the properties of albendazole–chitosan microparticles. J Pharm Biomed Anal 2008;48:802–7
   PubMed Web of Science ®Google Scholar
• Swain S, Behera UA, Beg S, et al. Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium. Drug Dev Ind Pharm 2013;39:548–60
   PubMed Web of Science ®Google Scholar
• Piccirilli G, García A, Leonardi D, et al. Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.829486
   Web of Science ®Google Scholar
• European Pharmacopoeia. 8th ed. Strasbourg, France; 2013
   Google Scholar
• Tansel B, Nagarajan P. SEM study of phenolphthalein adsorption on granular activated carbon. Adv Environ Res 2004;8:411–15
   Google Scholar
• Adami R, Reverchon E. Composite polymer-Fe3O4 microparticles for biomedical applications, produced by Supercritical Assisted Atomization. Powder Technol 2012;218:102–8
   Web of Science ®Google Scholar
• Singh I, Kumar P. Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram. Acta Pol Pharm 2012;69:87–93
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33
   PubMed Web of Science ®Google Scholar
• Dib A, Palma S, Suarez G, et al. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs. J Vet Pharmacol Ther 2011;34:136–41
   PubMed Web of Science ®Google Scholar
• Kitzman D, Cheng KJ, Fleckenstein L. HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. J Pharm Biomed Anal 2002;30:801–13
   PubMed Web of Science ®Google Scholar